The importance of microbial chemical interactions has gone virtually unnoticed, until recently, because most of these organisms can't grow in pure cultures of a single species, and are therefore difficult to cultivate in laboratory settings. But now, companies like Second Genome, run by Mr. Andersen, believe that by studying interactions between microbes and our bodies' own gastro-chemistry, new treatments could be developed. The company is currently investigating the microbiome's effect on inflammatory and metabolic disorders, including type 2 diabetes.
- More Here
- More Here
No comments:
Post a Comment